{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:13:00Z","timestamp":1787008380577,"version":"build-2736575974"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe how pharmacists can enhance the care of individuals with chronic kidney disease by examining the role of the pharmacist in new care models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The implications of chronic kidney disease for the healthcare system, particularly for the Centers for Medicare and Medicaid Services, are profound. New payment models and the development of medications that slow progression of kidney disease are transforming the landscape of nephrology care in the US. Pharmacists can play a pivotal role as part of the interdisciplinary care team to optimize medication therapy for this population. In particular, the Kidney Care Choices value-based care model is encouraging a more holistic approach to managing kidney disease that aligns with the goals of comprehensive medication management by pharmacists. Pharmacists can leverage fee-for-service and value-based care reimbursement models in primary care and nephrology care settings to successfully implement guideline-directed medical therapy for patients with chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The changing landscape of nephrology offers many opportunities for pharmacists to enhance patient care. More studies are needed to demonstrate the cost-effectiveness of pharmacists in this specialty to promote the expansion and impact of this role.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf048","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:30:48Z","timestamp":1740641448000},"page":"672-680","source":"Crossref","is-referenced-by-count":3,"title":["The pharmacist\u2019s role in transforming nephrology care"],"prefix":"10.1093","volume":"82","author":[{"given":"Melissa R","family":"Laub","sequence":"first","affiliation":[{"name":"Kidneylink, US Renal Care , Plano, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T","family":"Conway","sequence":"additional","affiliation":[{"name":"American Association of Kidney Patients , Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Trzebinska","sequence":"additional","affiliation":[{"name":"Kidneylink, US Renal Care , Plano, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Wargo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Legacy Health , Portland, OR ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Condon Martinez","sequence":"additional","affiliation":[{"name":"FreseniusRx, Fresenius Medical Care North America , Franklin, TN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"2025061121162739500_CIT0001","article-title":"CKD in the general population","volume-title":"2023 Annual Data Report: Chronic Kidney Disease","author":"US Renal Data System","year":"2023"},{"key":"2025061121162739500_CIT0002","article-title":"Mortality","volume-title":"2023 Annual Data Report: End-Stage Renal Disease. US Renal Data System","author":"US Renal Data System","year":"2023"},{"key":"2025061121162739500_CIT0003","article-title":"Healthcare expenditures for persons with CKD","volume-title":"2023 Annual Data Report: Chronic Kidney Disease","author":"US Renal Data System","year":"2023"},{"key":"2025061121162739500_CIT0004","author":"Department of Health and Human Services"},{"issue":"8","key":"2025061121162739500_CIT0005","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/jcm10081788","article-title":"Effectiveness of clinical pharmacist service on drug-related problems and patient outcomes for hospitalized patients with chronic kidney disease: a randomized controlled trial","volume":"10","author":"Song","year":"2021","journal-title":"J Clin Med"},{"issue":"11","key":"2025061121162739500_CIT0006","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1177\/1060028013501802","article-title":"Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews","volume":"47","author":"Salgado","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2025061121162739500_CIT0007","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2017.07.012","article-title":"Effectiveness of pharmacist interventions on cardiovascular risk in patients with CKD: a subgroup analysis of the randomized controlled RxEACH trial","volume":"71","author":"Al Hamarneh","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2025061121162739500_CIT0008","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm."},{"issue":"4","key":"2025061121162739500_CIT0009","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/jgs.14809","article-title":"Inappropriate medication in non-hospitalized patients with renal insufficiency: a systematic review","volume":"65","author":"D\u00f6rks","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"22","key":"2025061121162739500_CIT0010","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.jacc.2021.10.018","article-title":"The evolution of the quintuple aim","volume":"78","author":"Itchhaporia","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2025061121162739500_CIT0011","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/jac5.1796","article-title":"Collaboration between pharmacists in community pharmacy and ambulatory clinic settings: current state and future directions","volume":"6","author":"Cochran","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"issue":"6","key":"2025061121162739500_CIT0012","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jama.2021.25181","article-title":"The quintuple aim for health care improvement: a new imperative to advance health equity","volume":"327","author":"Nundy","year":"2022","journal-title":"JAMA"},{"key":"2025061121162739500_CIT0013","author":"American Society of Health-System Pharmacists","year":"2019","journal-title":"Pharmacist billing using \u201cincident-to\u201d rules non-facility (physician-based) ambulatory clinic\u2014FAQ"},{"key":"2025061121162739500_CIT0014","author":"American Society of Health-System Pharmacists","year":"2019"},{"issue":"5","key":"2025061121162739500_CIT0015","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/ajhp\/zxac352","article-title":"Ambulatory care pharmacy practice: findings from the 2019 National Pharmacist Workforce Survey","volume":"80","author":"Bakken","year":"2023","journal-title":"Am J Health-Syst Pharm"},{"key":"2025061121162739500_CIT0016","volume-title":"State Operations Manual","author":"Centers for Medicare and Medicaid Services","year":"2019"},{"key":"2025061121162739500_CIT0017","volume-title":"Bylaws of Independent Network of Volunteers for Equitable and Safe Transplants, Inc","author":"Organ Procurement and Transplantation Network","year":"2023"},{"issue":"9","key":"2025061121162739500_CIT0018","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ajt.2023.04.032","article-title":"The expanded role of the transplant pharmacist: a 10-year follow-up","volume":"23","author":"Lichvar","year":"2023","journal-title":"Am J Transplant"},{"issue":"2","key":"2025061121162739500_CIT0019","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2146\/ajhp110328","article-title":"Billing for outpatient transplant pharmacy services","volume":"69","author":"Maldonado","year":"2012","journal-title":"Am J Health-Syst Pharm"},{"key":"2025061121162739500_CIT0020","author":"American Society of Health-System Pharmacists","year":"2018"},{"key":"2025061121162739500_CIT0021","author":"National Committee for Quality Assurance"},{"key":"2025061121162739500_CIT0022","author":"Centers for Medicare and Medicaid Services"},{"key":"2025061121162739500_CIT0023","volume-title":"Kidney Care Choices Model Quality Operating Guide: Performance Year 2024 Benchmarks","author":"Centers for Medicare and Medicaid Services","year":"2023"},{"issue":"2","key":"2025061121162739500_CIT0024","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3122\/jabfm.2021.02.190318","article-title":"How comprehensive medication management contributes to foundational elements of primary care","volume":"34","author":"Funk","year":"2021","journal-title":"J Am Board Fam Med"},{"issue":"11","key":"2025061121162739500_CIT0025","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jchf.2023.08.015","article-title":"Polypharmacy; the clinical inertia conundrum for GDMT","volume":"11","author":"Page","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2025061121162739500_CIT0026","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","article-title":"Assessing the impact of comprehensive medication management on achievement of the quadruple aim","volume":"134","author":"McFarland","year":"2021","journal-title":"Am J Med"},{"issue":"5","key":"2025061121162739500_CIT0027","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.kint.2021.07.029","article-title":"The state of the global nephrology workforce: a joint ASN\u2013ERA-EDTA\u2013ISN investigation","volume":"100","author":"Sozio","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"2025061121162739500_CIT0028","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2025061121162739500_CIT0029","article-title":"Acute kidney injury","volume-title":"2023 Annual Data Report: Chronic Kidney Disease","author":"US Renal Data System","year":"2023"},{"issue":"12","key":"2025061121162739500_CIT0030","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/10600280241240409","article-title":"Role of a pharmacist in postdischarge care for patients with kidney disease: a scoping review","volume":"58","author":"Manis","year":"2024","journal-title":"Ann Pharmacother"},{"key":"2025061121162739500_CIT0031","author":"Centers for Disease Control and Prevention"},{"issue":"6","key":"2025061121162739500_CIT0032","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1159\/000507774","article-title":"Chronic kidney disease awareness and longitudinal health outcomes: results from the REasons for Geographic And Racial Differences in Stroke study","volume":"51","author":"Tummalapalli","year":"2020","journal-title":"Am J Nephrol"},{"issue":"2","key":"2025061121162739500_CIT0033","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.ajkd.2020.01.007","article-title":"CKD awareness among US adults by future risk of kidney failure","volume":"76","author":"Chu","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2025061121162739500_CIT0034","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2215\/CJN.00900120","article-title":"Patient and caregiver perspectives on terms used to describe kidney health","volume":"15","author":"Tong","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2025061121162739500_CIT0035","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2215\/CJN.08730620","article-title":"Nephrology nomenclature: how to accelerate patient anxiety, suppress engagement, and mire the advance of medical innovation","volume":"15","author":"Conway","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025061121162739500_CIT0036","article-title":"AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this \u2018silent disease\u2019","author":"Adams","year":"2022"},{"issue":"7","key":"2025061121162739500_CIT0037","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1681\/ASN.2019121331","article-title":"Measuring patient activation as part of kidney disease policy: are we there yet","volume":"31","author":"Nair","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2025061121162739500_CIT0038","doi-asserted-by":"publisher","first-page":"185","DOI":"10.18553\/jmcp.2010.16.3.185","article-title":"Medication therapy management: 10 years of experience in a large integrated health care system","volume":"16","author":"Ramalho de Oliveira","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"2025061121162739500_CIT0039","article-title":"Global Kidney Leadership & Innovation Award acceptance speech","volume-title":"5th Annual Global Summit on Kidney Disease Innovations","author":"Azar","year":"2023"},{"key":"2025061121162739500_CIT0040","article-title":"US kidney","author":"Azar","year":"2024","journal-title":"The Hill"},{"key":"2025061121162739500_CIT0041","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025061121162739500_CIT0042","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/IPRP.S108047","article-title":"Role of the pharmacist in reducing healthcare costs: current insights","volume":"6","author":"Dalton","year":"2017","journal-title":"Integr Pharm Res Pract"},{"issue":"4","key":"2025061121162739500_CIT0043","doi-asserted-by":"publisher","first-page":"e0406","DOI":"10.1097\/CCE.0000000000000406","article-title":"PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM study","volume":"3","author":"Rech","year":"2021","journal-title":"Crit Care Explor"},{"issue":"11","key":"2025061121162739500_CIT0044","doi-asserted-by":"publisher","first-page":"e2341408","DOI":"10.1001\/jamanetworkopen.2023.41408","article-title":"Cost-effectiveness of pharmacist prescribing for managing hypertension in the United States","volume":"6","author":"Dixon","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf048\/62572964\/zxaf048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/12\/672\/62572964\/zxaf048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/12\/672\/62572964\/zxaf048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T21:16:38Z","timestamp":1749676598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/12\/672\/8092354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,6,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf048","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,3,28]]}}}